baber/WOPTO huggingface dataset:
Patent DE-60327040-D1 (DE)
Inventor: KEY PETER B
IPC: G06F9/46
Filed: 2003-12-17
Granted: 2009-05-20
Abstract: Real time communications over a network are adjusted to improve the quality of service (QoS) under incipient congestion conditions. The system detects incipient network congestion and feeds back information regarding the incipient congestion back to the transmitter. Based on this information, the transmission rate is altered appropriately using a control algorithm, which computes the altered transmission rate based on a weight parameter, a gain parameter, and information from a congestion report. The altered transmission rate improves the transmitter's use of the available bandwidth to maintain an acceptable QoS at the receiver.
Patent DE-60327896-D1 (DE)
Inventor: PLUCIENNICZAK ANDRZEJ
IPC: C07K14/18
Filed: 2003-12-31
Granted: 2009-07-16
Abstract: An oral vaccine and the application of inclusion bodies in the production of oral vaccines against disease caused by a pestivirus, particularly against Classical Swine Fever.
Patent DE-60328298-D1 (DE)
Inventor: LIPPONEN PENTTI
IPC: B64F1/06
Filed: 2003-09-12
Granted: 2009-08-20
Abstract: A catapult for launching an unmanned aircraft. The catapult comprises a first carriage, to which the aircraft ( 5 ) can be arranged. The catapult further comprises a launching cylinder ( 23 ) that is arranged to move the carriage ( 4 ) in the launch direction (B) by means of a pulling element, such as a rope, and also a pulley mechanism. The carriage can be moved in the return direction (C) by means of a returning device ( 31 ) and a return-side pulley mechanism ( 51 ).
Patent DE-60328724-D1 (DE)
Inventor: WONG LOK YUNG
IPC: E06B9/11
Filed: 2003-10-17
Granted: 2009-09-17
Abstract: A rolling door or shutter ( 1 ) has a series of preferably planar panels ( 3, 3 A) which are joined by pairs ( 6 ) of pivotally connected hinge members ( 7, 8 ). The shutter slides up and down with its side edges guided in tracks ( 2 ). When the shutter is closed, e.g. against a bottom sill, the hinge members of each pair ( 6 ) pivot about one another to jam between opposing walls ( 30, 31 ) of the guide tracks. The pivotal range of each hinge pair may be limited to prevent the hinge pair from straightening when the shutter is suspended. This ensures the hinge pairs always fold in the same way when the shutter is closed. The panels may be rolled steel, extruded aluminium, moulded (optionally transparent) polycarbonate plastic, or tempered glass sheets fitted with edge cappings.
Patent DE-60328970-D1 (DE)
Inventor: MILLS DESMOND BRYAN
IPC: A61N1/00
Filed: 2003-03-10
Granted: 2009-10-08
Abstract: A medical device, such as an automatic external defibrillator (AED), and it comprises a housing with an aperture 6 in the form of a slot. At either side of the opening of the aperture, there are electrical connectors 8 and insertion of the electrode 5 in the aperture 6 forces apart the connectors. The medical device includes a circuit comprising a power source 2, a switching circuit 3 and capacitors 4 that can deliver charge to electrodes 5 when placed on the patient's chest during treatment. When the electrode is inserted in the aperture 6, the connectors 8 are held apart, thereby breaking the circuit. However, when the electrode is removed from the aperture 6, tension in the spring connectors 8 is released the circuit of the medical device is completed and is activated by the flow of charge from the battery 2. When the circuit is completed, the medical device may be ready for activation or alternatively, depending on how the medical device is set up, a self-test mechanism may be activated to check the condition of the medical device and/or electrode(s) 5 prior to use on a patient.
Patent DE-60331582-D1 (DE)
Inventor: MONTAGNE LOUIS
IPC: H05B44/00
Filed: 2003-11-11
Granted: 2010-04-15
Abstract: The invention relates to a luminaire comprising a plurality of light sources fixedly located in a plurality of positions and comprising at least an electroluminescent diode. Said sources are focused by the same optical system fixed relative to the plurality of sources. Said luminaire comprises electronic means for dimming sources in their emission intensity independently of one another and as a function of their respective positions relative to said optical system. The invention provides an output beam having a dimmable photometric distribution in time and in space at the output of said optical system.
Patent DE-60333675-D1 (DE)
Inventor: MCCLOSKEY PATRICK JOSEPH
IPC: C08L67/00
Filed: 2003-12-10
Granted: 2010-09-16
Abstract: Polycarbonates containing low or undetectable levels of Fries rearrangement products and comprising repeat units derived from one or more of resorcinol, hydroquinone, methylhydroquinone, bisphenol A, and 4,4'-biphenol have been prepared by the melt reaction of one or more of the aforementioned dihydroxy aromatic compounds with an ester-substituted diaryl carbonate such as bis-methyl salicyl carbonate. Low, or in many instances undetectable, levels of Fries rearrangement products are found in the product polycarbonates obtained as the combined result of a highly effective catalyst system which suppresses the Fries reaction and the use of lower melt polymerization temperatures relative to temperatures required for the analogous polymerization reactions using diphenyl carbonate.
Patent DE-68903547-D1 (DE)
Inventor: BREARD FRANCIS HENRI
IPC: A61F2/36
Filed: 1989-09-15
Granted: 1992-12-24
Abstract: The present invention relates to an articulation prosthesis, in particular a hip prosthesis, consisting of an elongate body comprising an intramedullary rod and a body receiving a spherical head (3), this body being subdivided, in the direction of its length, into a part (4b) for supporting the spherical head and a part (1b) for anchoring in the bone, these parts being joined to one another by way of a damping connection, preferably defined by a direct connection of these parts which is formed, on the external face of the prosthesis, by a joining branch (11) holding the first part upright on the second part. In a preferred embodiment, the support part consists of a specially designed neck (4b) in the shape of a swan's neck, attached to the rod (1b), which forms the anchoring part, on its external face, this neck being profiled in such a way as to delimit with its base a recess (19) formed in the face opposite the rod, a rounded cavity (20) opening out on the inner face of the body of the prosthesis. <IMAGE>
Patent DE-68922860-D1 (DE)
Inventor: GOPALAKRISHNAN JAGANNATHA
IPC: C04B35/00
Filed: 1989-10-06
Granted: 1995-06-29
Abstract: Compositions having the nominal formula PbaRbCacSrdCueOx wherein R is one or more elements selected from the group consisting of yttrium and the lanthanides with atomic numbers 57 to 71, a is from about 1/2 to 5, b is from about 1/10 to 2, c is from about 1/2 to 4, d is from about 1/2 to 4, e is from about 3 to 6, x = (a+b+c+d+e+y) where y is from about 1/2 to 3, are superconducting. Processes for manufacturing such compositions and for using them are disclosed.
Patent DE-68923138-D1 (DE)
Inventor: FRASER MICHAEL JAMES
IPC: F01D5/00
Filed: 1989-09-15
Granted: 1995-07-27
Abstract: A method of and apparatus for repairing turbine blades (11-14) wherein the repair requires the input of considerable thermal energy during a welding or brazing operation for example. The method involves the step of predistorting the blade prior to the welding or brazing operation so that the distortion that is expected to occur during welding or brazing leaves the blade after repair in its proper position. A clamp means (17) may be provided to prevent parts of an individual blade from being predistorted so as to localise the predistortion in the required area. A tool (113) for predistorting the blade ensures that a physical force may be applied to a local area of the blade.
Patent DE-69001988-D1 (DE)
Inventor: UENO RYUJI
IPC: A61P43/00
Filed: 1990-10-11
Granted: 1993-07-22
Abstract: A use of a cyclodextrin or a derivative thereof for the manufacture of a medicament for treatment of shock.
Patent DE-69010675-D1 (DE)
Inventor: THRANE MORTEN
IPC: H04M9/08
Filed: 1990-12-21
Granted: 1994-08-18
Abstract: This invention relates to an echo canceller such as for use in a full duplex hands free radio. The echo canceller is particularly suitable for use in a vehicle fitted with a microphone and a loudspeaker, for cancelling echos reach the radio microphone (16) from the radio loudspeaker (13). The signal paths are divided into sub-band channels (Y1-YM). Each of the channels has an adaptive filter (24, 29, 30), a time delay coefficient of which is dynamically adjustable. Means are provided for cancelling echos by compensating the signal on each channel as a function of the signal from the filter, and means (S1, Si, SM) are provided for initiating and suspending the adjustment of the coefficient of each channel filter as a function of the signal on that channel (X1-XM and/or Y1-YM).
Patent DE-69013155-D1 (DE)
Inventor: BINDERUP ERNST
IPC: C07C401/00
Filed: 1990-07-04
Granted: 1994-11-10
Abstract: PCT No. PCT/DK90/00168 Sec. 371 Date Nov. 19, 1991 Sec. 102(e) Date Nov. 19, 1991 PCT Filed Jul. 4, 1990 PCT Pub. No. WO91/00855 PCT Pub. Date Jan. 24, 1991.   <IMAGE> (I)  The present invention relates to compounds of formula (I), in which formula n is 2 or 3, m is 0 or an integer from 1-4; R1 and R2 (which may be the same or different) stand for hydrogen or C1-C8-hydrocarbyl, hydrocarbyl indicating the residue after removal of a hydrogen atom from a straight, branched or cyclic saturated or unsaturated hydrocarbon, or taken together with the carbon bearing the hydroxyl group (starred in formula (I)), R1 and R2 can form a saturated or unsaturated C3-C8 carboxylic ring; in addition, R1 and/or R2 and/or one of the m carbons designated by the " DEG " may be optionally substituted with one or more chlorine or fluorine atom(s); and finally one of the carbons designated " DEG " may optionally be substituted by one or two C1-C2 alkyl group(s); and derivatives of the compounds of formula (I) in which one or more hydroxy have been transformed into -O-acyl or O-glycosyl or phosphate ester groups; such masked groups being hydrolyzable in vivo. The present compounds find use in both the human and vertinary practice in the treatment and prophylaxis of autoimmune diseases (including diabetes mellitus), hypertension, acne, alopecia, skin ageing, imbalance in the immune system, inflammatory diseases such as rheumatoid arthritis and asthma as well as diseases characterized by abnormal cell differentiation and/or cell proliferation, such as e.g. psoriasis and cancer.
Patent DE-69015453-D1 (DE)
Inventor: YAMAGATA SHIGERU
IPC: C03B32/00
Filed: 1990-06-08
Granted: 1995-02-09
Abstract: The invention relates to lenses, prisms or other optical members which are subjected to high-power ultraviolet light having a wavelength of about 360 nm or less, or ionizing radiation, particularly optical members for use in laser exposure apparatus for lithography, and to blanks for such optical members. The homogeneity of the refractive index distribution and the resistance to optical deterioration when the optical members are exposed for a long period of time to short wavelength ultraviolet light from a laser beam are improved. The optical members are made of high-purity synthetic silica glass material containing at least about 50 wt. ppm of OH groups, and are doped with hydrogen. The refractive index distribution caused by the fictive temperature distribution during heat treatment in the process of producing high-purity silica glass blanks for optical members in accordance with the present invention is offset by the combined refractive index distribution determined by the OH group concentration distribution or by the OH group concentration distribution and the Cl concentration distribution in the glass.
Patent DE-69031433-D1 (DE)
Inventor: HETHERINGTON RICKY C
IPC: G06F9/38
Filed: 1990-01-31
Granted: 1997-10-23
Abstract: A technique for processing memory access exceptions along with pre-fetched instructions in a pipelined instruction processing computer system is based upon the concept of pipelining exception information along with other parts of the instruction being executed. In response to the detection of access exceptions at a pipeline stage, corresponding fault information is generated and transferred along the pipeline. The fault information is acted upon only when the instruction reaches the execution stage(20) of the pipeline. Each stage of the instruction pipeline is ported into the front end of a memory unit (16) adapted to perform the virtual-to-physical address translation; each port being provided with means for storing virtual addresses accompanying an instruction as well as means for storing corresponding fault information. When a memory access exception is encountered at the front end of the memory unit, the fault information generated therefrom is loaded into the storage means and the port is prevented from accepting further references.
Patent DE-69110663-D1 (DE)
Inventor: LOOSEN PIERRE
IPC: C07K14/00
Filed: 1991-01-11
Granted: 1995-07-27
Abstract: PCT No. PCT/BE91/00001 Sec. 371 Date Sep. 4, 1992 Sec. 102(e) Date Sep. 4, 1992 PCT Filed Sep. 11, 1991 PCT Pub. No. WO91/10369 PCT Pub. Date Jul. 25, 1991.An enzymatic hydrolysate having a high di- and tripeptide content is prepared by subjecting to enzymatic proteolysis a protein mixture preliminarily prepared by means of a thermal treatment. The hydrolysate having a high di- and tripeptide content is extracted by liquid-solid separation, followed by ultrafiltration. The hydrolysate is then subjected to a sterilization and drying operation.
Patent DE-69116791-D1 (DE)
Inventor: SHIBUYA TAKASHI
IPC: A23L27/30
Filed: 1991-10-04
Granted: 1996-03-14
Abstract: Lactoneotrehalose, a novel saccharide shown by the formula O- beta -D-galactopyranosyl-(1->4)-O- beta -D-glucopyranosyl  alpha -D-glucopyranoside, is prepared by allowing a saccharide-transferring enzyme to act on an aqueous solution containing lactose and amylaceous substance. Lactoneotrehalose is a non-reducing oligosaccharide, extremely stable, readily soluble in water, and substantially free of hygroscopicity, as well as having a satisfiable quality and moderate sweetness. These render lactoneotrehalose very useful in the preparations of orally-administrable products, cosmetics and pharmaceuticals.
Patent DE-69123850-D1 (DE)
Inventor: CONRADIE WILHEIM EDUARD KENT S
IPC: B27K3/50
Filed: 1991-09-02
Granted: 1997-02-06
Abstract: PCT No. PCT/GB91/01480 Sec. 371 Date May 3, 1993 Sec. 102(e) Date May 3, 1993 PCT Filed Sep. 2, 1991 PCT Pub. No. WO92/04166 PCT Pub. Date Mar. 19, 1992.A wood preservative composition including a mixture of two or more metallic soaps of long chain unsaturated fatty acids, which soaps have a metallic component selected from the group consisting of copper, zinc, chromium, iron, antimony, tin, cobalt, nickel, arsenic, boron, lead, magnesium, potassium and sodium, and a fatty acid component selected from two or more of the group consisting of oleic acid, linoleic acid, and linolenic acid, the composition being such that the ratio by mass of metallic soap of oleic acid:metallic soap of linoleic acid:metallic soap of linolenic acid is about 20-29:15-70:0-47.
Patent DE-69128465-D1 (DE)
Inventor: COOK JACQUELYNN
IPC: A61P43/00
Filed: 1991-02-14
Granted: 1998-01-29
Abstract: Circulating heparin in a mammal may be neutralized without substantial depletion of platelets or leukocytes by administering to the mammal a heparin neutralizing amount of purified PF4 or rPF4 or a heparin neutralizing fragment thereof.
Patent DE-69129057-D1 (DE)
Inventor: CIPOLLI ROBERTO DR
IPC: C08K5/43
Filed: 1991-10-31
Granted: 1998-04-16
Abstract: Disclosed are self-extinguishing polymeric compositions comprising     a) from 89 to 40 parts by weight of thermoplastic polymer or of polymer having elastomeric properties; b) from 8 to 33 parts by weight of one or more ammonium and/or amine phosphates and/or phosphonates; c) from 3 to 27 parts by weight of one or more oligomeric compounds having 2 to 50 repeating units of general formula (I):   <CHEM> wherein R and Z are defined as in claim 1. i
Patent DE-69133348-D1 (DE)
Inventor: BORODY THOMAS JULIUS
IPC: A61P29/00
Filed: 1991-10-17
Granted: 2004-01-29
Abstract: A medicine for treating non-inflammatory and non-infectious bowel disorders, such as irritable bowel syndrome, constipation, non-ulcer dyspepsia, gastro-oesophageal reflux with or without oesophagitis, and diverticular disease, comprising a salicylic acid derivative, such as any one of sulfasalazine, 5-aminosalicylic acid, 4-aminosalicylic acid, and benzalazine, or a combination of any two or more thereof. The treatment of those disorders comprises taking the medicine by mouth to provide a dosage rate of the salicylic acid derivative of from 200 mg to 18 g per day.
Patent DE-69216400-D1 (DE)
Inventor: ENLUND PENTTI
IPC: E21B21/14
Filed: 1992-05-05
Granted: 1997-02-13
Abstract: PCT No. PCT/FI92/00143 Sec. 371 Date Nov. 12, 1993 Sec. 102(e) Date Nov. 12, 1993 PCT Filed May 5, 1992 PCT Pub. No. WO92/20898 PCT Pub. Date Nov. 26, 1992.A method and an arrangement for controlling the supply of air into a rock drilling machine. In the method, the air supply of an air compressor in a power unit operated by a diesel engine is adjusted so that when the percussion pressure of the percussion device of the rock drilling machine is high, the amount of air supplied by the compressor is small, and vice versa. In the arrangement, the pressure fluid pump of the hydraulic motor of the compressor is an adjustable-displacement pump, the volume flow of the pressure fluid supplied by the pump being adjusted inversely proportionally to the pressure of the supply conduit of the percussion device of the rock drilling machine.
Patent DE-69231207-D1 (DE)
Inventor: FETTO JOSEPH
IPC: A61F2/00
Filed: 1992-04-22
Granted: 2000-08-03
Abstract: A femoral component of a hip endoprosthesis includes a lateral supporting wedge designed to be supported by the proximal lateral femur when in use. The wedge can be an integral part of the material of the femoral component or it can be placed on a standard component by cementing or preferably by a male/female socket fit. The lateral surface of the wedge forms an angle of about 10 DEG -20 DEG  with the midline of the distal portion of the stem and has an anterior-posterior width of about 8.30 mm, preferably about 10-20 mm, and a medial-lateral extension of the lateral surface of the stem of at least 10 mm, preferably 10-30 mm. An apparatus for testing the endurance of femoral components includes a cable corresponding to the ilio-tibial band. Such an apparatus more accurately models hip biomechanics and thus permits a more accurate test of the stresses on femoral component designs.
Patent DE-69300126-D1 (DE)
Inventor: COUTTS JENNIFER RUTH
IPC: C09B67/46
Filed: 1993-03-24
Granted: 1995-06-01
Abstract: For paints and the like, an aqueous tinter which does not block dispensing nozzles and which has a viscosity of from 0.05 to 1.5 Ns/m<2> (20 DEG C) and which contains pigment particles, water, micellising dispersant and a non-micellising auxiliary material. The weight ratio of dispersant to pigment must exceed the ratio which would be present at the Daniel Flow Point for a notional tinter consisting only of the pigment, water and the dispersant. The amount of auxiliary material must be sufficient to enable the tinter to be expelled through a bore 2mm in diameter and 15mm long by a pressure of not more than 320 MN/m<2> after storage in the bore at 25 DEG C for 18 hours under a relative humidity of 50%. Preferred dispersants comprise long chain hydrophilic and long chain hydrophobic moieties which may be poly(alkylene glycol) esters of long chain fatty acids or hydrophobic backbone copolymers with pendant poly(alkylene glycol) moieties as hydrophilic side chains.
Patent DE-69304528-D1 (DE)
Inventor: BERGMANN ANDREAS
IPC: G01N33/58
Filed: 1993-04-22
Granted: 1996-10-10
Abstract: PCT No. PCT/EP93/00981 Sec. 371 Date Jan. 17, 1995 Sec. 102(e) Date Jan. 17, 1995 PCT Filed Apr. 22, 1993 PCT Pub. No. WO93/22675 PCT Pub. Date Nov. 11, 1993A method is revealed for the quantitative determination of the proportion of the free form of a thyroid hormone ligand in a sample of a biological fluid in which the ligand is present partly in the free form and also partly in a form in which it is bound to physiological binding proteins. In the first step, a ligand derivative of the thyroid hormone with an immunoglobulin, a labelled specific binder, and a test tube whose walls are coated with an excess of a protein material are provided. In the second step, a sample of the biological fluid containing an unknown amount of the free thyroid hormone ligand, a solution containing a known amount of the ligand derivative, and a solution containing a known, less than stoichiometric amount of the labelled specific binder are added to the test tube to form a liquid reaction mixture. In the third step, the reaction mixture is incubated to allow the free thyroid hormone ligand and the ligand derivative in the liquid reaction mixture to compete for the binding sites of the labelled specific binder, and to allow, in a concomitant slower reaction, the binding of the immunoglobulin part of the ligand derivative to the excess of the protein material on the walls of the test tube. In the fourth step, the remaining liquid reaction mixture is removed from the test tube. In the final steps, the amount of labelled specific binder bound to the walls of the test tube is determined and the amount of the free thyroid hormone ligand calculated.
Patent DE-69308167-D1 (DE)
Inventor: SOZANSKI JEAN-PIERRE
IPC: A61N5/02
Filed: 1993-04-06
Granted: 1997-03-27
Abstract: The invention relates to a microwave device inducing hyperthermia in a given body. The device comprises a wire antenna (1) supplied with microwave energy or, upon being switched, acting as a radiometric probe, a sleeve (2) permitting the thermostatting of the wire antenna, and a Foley-type catheter (3) mounted in a removable manner in such a way as to encompass the assembly thus formed, the catheter making it possible to position this assembly with respect to an inlet opening in the given body, and being the only disposable part in order to ensure satisfactory hygiene during the hyperthermia session. A connection module (4) permits interconnection both radioelectrically in respect of the wire antenna and hydraulically in respect of the sleeve and the catheter. Application to thermotherapy or heat treatment of given bodies. <IMAGE>
Patent DE-69313978-D1 (DE)
Inventor: AUDOUSSET MARIE-PASCALE
IPC: H04B10/12
Filed: 1993-11-19
Granted: 1997-10-23
Abstract: The invention relates to the use of 4-hydroxy- or 4-aminobenzimidazole or derivatives thereof, corresponding to the formula (I): <IMAGE>  in which:   R1 and R2 represent hydrogen or alkyl; at least one of the substituents being equal to hydrogen;   R3 denotes OH or NH2, as a coupling agent for dyeing keratinous fibres, in particular hair, in the presence of a p-phenylenediamine, the ratio between the p-phenylenediamine and the coupling agent of formula (I) being greater than or equal to 1.2.
Patent DE-69325036-D1 (DE)
Inventor: HORNE GRAHAM ROBERT
IPC: C11D3/39
Filed: 1993-12-15
Granted: 1999-06-24
Abstract: PCT No. PCT/GB93/02552 Sec. 371 Date Jun. 21, 1995 Sec. 102(e) Date Jun. 21, 1995 PCT Filed Dec. 15, 1993 PCT Pub. No. WO94/14702 PCT Pub. Date Jul. 7, 1994A process for stabilising percarbonate by coating with a coating agent. The percarbonate particles are treated with a concentrated aqueous solution containing at least one boron compound selected from the metal and ortho boric acids and at least one phosphate. Water is removed to provide the coated percarbonate particles which are useful in bleaching and washing compositions.
Patent DE-69326559-D1 (DE)
Inventor: HARKKI ANU
IPC: C12P19/02
Filed: 1993-11-05
Granted: 1999-10-28
Abstract: Novel methods for the synthesis of xylitol are described.